Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Feb 1;82(5):1051–1057. doi: 10.1054/bjoc.1999.1041

Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures

K Dhaene 1, G Vancoillie 2, J Lambert 2, J M Naeyaert 2, E Van Marck 1
PMCID: PMC2374429  PMID: 10737388

Abstract

The classic model of activation of telomerase, for which activity has been found in most cancers including cutaneous malignant melanoma (CMM), dictates that enzyme activity is generated by pathological reactivation of telomerase in telomerase-negative somatic cells. However, recent data demonstrated physiological up-regulation in some normal cell types when established as proliferating cultures, indicating that, in some cancer types, telomerase is expressed by the process of up-regulation in telomerase-competent precursor cells. In this study, cultures of epidermal melanocytes, progenitor cells of CMM, were established and harvested in the logarithmic phase of growth. Telomerase activity was looked for using a non-isotopic variant of the telomeric repeat amplification protocol, and transcript expression of the hTERT gene, the rate-limiting catalytic telomerase subunit, was investigated by the reverse transcription polymerase chain reaction. Neither telomerase activity nor hTERT mRNA could be detected in proliferating melanocyte cultures. Our in vitro data argue against the model of telomerase as a common biomarker of cell proliferation. The results further suggest that telomerase is tightly controlled in normal melanocytes, and that telomerase is reactivated rather than up-regulated in melanocytic precursors during melanoma initiation or progression. © 2000 Cancer Research Campaign

Keywords: telomerase, melanoma, hTERT, proliferation, Ki-S2, Ki-S5

Full Text

The Full Text of this article is available as a PDF (228.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman A. B. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology. 1988 Sep;13(3):241–256. doi: 10.1111/j.1365-2559.1988.tb02036.x. [DOI] [PubMed] [Google Scholar]
  2. Albino A. P. Genes involved in melanoma susceptibility and progression. Curr Opin Oncol. 1995 Mar;7(2):162–169. doi: 10.1097/00001622-199503000-00012. [DOI] [PubMed] [Google Scholar]
  3. Allsopp R. C., Chang E., Kashefi-Aazam M., Rogaev E. I., Piatyszek M. A., Shay J. W., Harley C. B. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res. 1995 Sep;220(1):194–200. doi: 10.1006/excr.1995.1306. [DOI] [PubMed] [Google Scholar]
  4. Balasubramanian S., Kim K. H., Ahmad N., Mukhtar H. Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. Oncogene. 1999 Feb 11;18(6):1297–1302. doi: 10.1038/sj.onc.1202417. [DOI] [PubMed] [Google Scholar]
  5. Belair C. D., Yeager T. R., Lopez P. M., Reznikoff C. A. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13677–13682. doi: 10.1073/pnas.94.25.13677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boyle P., Maisonneuve P., Doré J. F. Epidemiology of malignant melanoma. Br Med Bull. 1995 Jul;51(3):523–547. doi: 10.1093/oxfordjournals.bmb.a072978. [DOI] [PubMed] [Google Scholar]
  7. Briggs J. C. Melanoma precursor lesions and borderline melanomas. Histopathology. 1985 Dec;9(12):1251–1262. doi: 10.1111/j.1365-2559.1985.tb02808.x. [DOI] [PubMed] [Google Scholar]
  8. Cong Y. S., Wen J., Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet. 1999 Jan;8(1):137–142. doi: 10.1093/hmg/8.1.137. [DOI] [PubMed] [Google Scholar]
  9. Counter C. M., Avilion A. A., LeFeuvre C. E., Stewart N. G., Greider C. W., Harley C. B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 1992 May;11(5):1921–1929. doi: 10.1002/j.1460-2075.1992.tb05245.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Counter C. M., Gupta J., Harley C. B., Leber B., Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995 May 1;85(9):2315–2320. [PubMed] [Google Scholar]
  11. Cramer S. F. The origin of epidermal melanocytes. Implications for the histogenesis of nevi and melanomas. Arch Pathol Lab Med. 1991 Feb;115(2):115–119. [PubMed] [Google Scholar]
  12. Cuthbert A. P., Bond J., Trott D. A., Gill S., Broni J., Marriott A., Khoudoli G., Parkinson E. K., Cooper C. S., Newbold R. F. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst. 1999 Jan 6;91(1):37–45. doi: 10.1093/jnci/91.1.37. [DOI] [PubMed] [Google Scholar]
  13. Dhaene K., Hübner R., Kumar-Singh S., Weyn B., Van Marck E. Telomerase activity in human pleural mesothelioma. Thorax. 1998 Nov;53(11):915–918. doi: 10.1136/thx.53.11.915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Feng J., Funk W. D., Wang S. S., Weinrich S. L., Avilion A. A., Chiu C. P., Adams R. R., Chang E., Allsopp R. C., Yu J. The RNA component of human telomerase. Science. 1995 Sep 1;269(5228):1236–1241. doi: 10.1126/science.7544491. [DOI] [PubMed] [Google Scholar]
  15. Glaessl A., Bosserhoff A. K., Buettner R., Hohenleutner U., Landthaler M., Stolz W. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas. Arch Dermatol Res. 1999 Feb-Mar;291(2-3):81–87. doi: 10.1007/s004030050387. [DOI] [PubMed] [Google Scholar]
  16. Greaves M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet. 1996 Apr;12(4):127–128. doi: 10.1016/0168-9525(96)30016-4. [DOI] [PubMed] [Google Scholar]
  17. Greider C. W. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):90–92. doi: 10.1073/pnas.95.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harley C. B. Telomere loss: mitotic clock or genetic time bomb? Mutat Res. 1991 Mar-Nov;256(2-6):271–282. doi: 10.1016/0921-8734(91)90018-7. [DOI] [PubMed] [Google Scholar]
  19. Harrington L., McPhail T., Mar V., Zhou W., Oulton R., Bass M. B., Arruda I., Robinson M. O. A mammalian telomerase-associated protein. Science. 1997 Feb 14;275(5302):973–977. doi: 10.1126/science.275.5302.973. [DOI] [PubMed] [Google Scholar]
  20. Hastrup N., Osterlind A., Drzewiecki K. T., Hou-Jensen K. The presence of dysplastic nevus remnants in malignant melanomas. A population-based study of 551 malignant melanomas. Am J Dermatopathol. 1991 Aug;13(4):378–385. doi: 10.1097/00000372-199108000-00009. [DOI] [PubMed] [Google Scholar]
  21. Holt S. E., Aisner D. L., Shay J. W., Wright W. E. Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10687–10692. doi: 10.1073/pnas.94.20.10687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Holt S. E., Wright W. E., Shay J. W. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol. 1996 Jun;16(6):2932–2939. doi: 10.1128/mcb.16.6.2932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Härle-Bachor C., Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6476–6481. doi: 10.1073/pnas.93.13.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994 Dec 23;266(5193):2011–2015. doi: 10.1126/science.7605428. [DOI] [PubMed] [Google Scholar]
  25. Kipling D. Telomere structure and telomerase expression during mouse development and tumorigenesis. Eur J Cancer. 1997 Apr;33(5):792–800. doi: 10.1016/S0959-8049(97)00060-9. [DOI] [PubMed] [Google Scholar]
  26. Klingel R., Mincheva A., Kahn T., Gissmann L., Dippold W., Meyer zum Büschenfelde K. H., zur Hausen H. An amplification unit in human melanoma cells showing partial homology with sequences of human papillomavirus type 9 and with nuclear antigen 1 of the Epstein-Barr virus. Cancer Res. 1987 Aug 15;47(16):4485–4492. [PubMed] [Google Scholar]
  27. Kolquist K. A., Ellisen L. W., Counter C. M., Meyerson M., Tan L. K., Weinberg R. A., Haber D. A., Gerald W. L. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet. 1998 Jun;19(2):182–186. doi: 10.1038/554. [DOI] [PubMed] [Google Scholar]
  28. Kreipe H., Wacker H. H., Heidebrecht H. J., Haas K., Hauberg M., Tiemann M., Parwaresch R. Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol. 1993 Jun;142(6):1689–1694. [PMC free article] [PubMed] [Google Scholar]
  29. Lambert J., Onderwater J., Vander Haeghen Y., Vancoillie G., Koerten H. K., Mommaas A. M., Naeyaert J. M. Myosin V colocalizes with melanosomes and subcortical actin bundles not associated with stress fibers in human epidermal melanocytes. J Invest Dermatol. 1998 Nov;111(5):835–840. doi: 10.1046/j.1523-1747.1998.00395.x. [DOI] [PubMed] [Google Scholar]
  30. Libow L. F., Scheide S., DeLeo V. A. Ultraviolet radiation acts as an independent mitogen for normal human melanocytes in culture. Pigment Cell Res. 1988;1(6):397–401. doi: 10.1111/j.1600-0749.1988.tb00142.x. [DOI] [PubMed] [Google Scholar]
  31. Mantell L. L., Greider C. W. Telomerase activity in germline and embryonic cells of Xenopus. EMBO J. 1994 Jul 1;13(13):3211–3217. doi: 10.1002/j.1460-2075.1994.tb06620.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Naeyaert J. M., Eller M., Gordon P. R., Park H. Y., Gilchrest B. A. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. Br J Dermatol. 1991 Oct;125(4):297–303. doi: 10.1111/j.1365-2133.1991.tb14161.x. [DOI] [PubMed] [Google Scholar]
  33. Nakamura T. M., Morin G. B., Chapman K. B., Weinrich S. L., Andrews W. H., Lingner J., Harley C. B., Cech T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997 Aug 15;277(5328):955–959. doi: 10.1126/science.277.5328.955. [DOI] [PubMed] [Google Scholar]
  34. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet. 1998 Jan;18(1):65–68. doi: 10.1038/ng0198-65. [DOI] [PubMed] [Google Scholar]
  35. Newbold R. F., Overell R. W., Connell J. R. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature. 1982 Oct 14;299(5884):633–635. doi: 10.1038/299633a0. [DOI] [PubMed] [Google Scholar]
  36. Pandita T. K., Hall E. J., Hei T. K., Piatyszek M. A., Wright W. E., Piao C. Q., Pandita R. K., Willey J. C., Geard C. R., Kastan M. B. Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny. Oncogene. 1996 Oct 3;13(7):1423–1430. [PubMed] [Google Scholar]
  37. Parris C. N., Jezzard S., Silver A., MacKie R., McGregor J. M., Newbold R. F. Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer. 1999 Jan;79(1):47–53. doi: 10.1038/sj.bjc.6690010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Quevedo W. C., Jr, Fleischmann R. D. Developmental biology of mammalian melanocytes. J Invest Dermatol. 1980 Jul;75(1):116–120. doi: 10.1111/1523-1747.ep12521335. [DOI] [PubMed] [Google Scholar]
  39. Ramakrishnan S., Eppenberger U., Mueller H., Shinkai Y., Narayanan R. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 1998 Feb 15;58(4):622–625. [PubMed] [Google Scholar]
  40. Rhyu M. S. Telomeres, telomerase, and immortality. J Natl Cancer Inst. 1995 Jun 21;87(12):884–894. doi: 10.1093/jnci/87.12.884. [DOI] [PubMed] [Google Scholar]
  41. Rudolph P., Knüchel R., Endl E., Heidebrecht H. J., Hofstäder F., Parwaresch R. The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen. Mod Pathol. 1998 May;11(5):450–456. [PubMed] [Google Scholar]
  42. Scheurlen W., Gissmann L., Gross G., zur Hausen H. Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int J Cancer. 1986 Apr 15;37(4):505–510. doi: 10.1002/ijc.2910370406. [DOI] [PubMed] [Google Scholar]
  43. Takamiyagi A., Asato T., Nakashima Y., Nonaka S. Association of human papillomavirus type 16 with malignant melanoma. Am J Dermatopathol. 1998 Feb;20(1):69–73. doi: 10.1097/00000372-199802000-00014. [DOI] [PubMed] [Google Scholar]
  44. Taylor R. S., Ramirez R. D., Ogoshi M., Chaffins M., Piatyszek M. A., Shay J. W. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol. 1996 Apr;106(4):759–765. doi: 10.1111/1523-1747.ep12345811. [DOI] [PubMed] [Google Scholar]
  45. Ueda M., Ouhtit A., Bito T., Nakazawa K., Lübbe J., Ichihashi M., Yamasaki H., Nakazawa H. Evidence for UV-associated activation of telomerase in human skin. Cancer Res. 1997 Feb 1;57(3):370–374. [PubMed] [Google Scholar]
  46. Ulaner G. A., Hu J. F., Vu T. H., Giudice L. C., Hoffman A. R. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 1998 Sep 15;58(18):4168–4172. [PubMed] [Google Scholar]
  47. Weterman M. A., van Muijen G. N., Bloemers H. P., Ruiter D. J. Molecular markers of melanocytic tumor progression. Lab Invest. 1994 May;70(5):593–608. [PubMed] [Google Scholar]
  48. Wright W. E., Pereira-Smith O. M., Shay J. W. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol. 1989 Jul;9(7):3088–3092. doi: 10.1128/mcb.9.7.3088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wu K. J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat Genet. 1999 Feb;21(2):220–224. doi: 10.1038/6010. [DOI] [PubMed] [Google Scholar]
  50. Wynford-Thomas D. Cellular senescence and cancer. J Pathol. 1999 Jan;187(1):100–111. doi: 10.1002/(SICI)1096-9896(199901)187:1<100::AID-PATH236>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  51. Yamada O., Motoji T., Mizoguchi H. Up-regulation of telomerase activity in human lymphocytes. Biochim Biophys Acta. 1996 Dec 12;1314(3):260–266. doi: 10.1016/s0167-4889(96)00104-8. [DOI] [PubMed] [Google Scholar]
  52. Zhu X., Kumar R., Mandal M., Sharma N., Sharma H. W., Dhingra U., Sokoloski J. A., Hsiao R., Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6091–6095. doi: 10.1073/pnas.93.12.6091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. de Lange T. Telomeres and senescence: ending the debate. Science. 1998 Jan 16;279(5349):334–335. doi: 10.1126/science.279.5349.334. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES